57
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Systemic ketoconazole continues to be prescribed despite an FDA warning

, &
Pages 1787-1788 | Received 27 Aug 2020, Accepted 18 Sep 2020, Published online: 19 Oct 2020
 

Acknowledgements

None.

Disclosure statement

Dr. Fleischer is a consultant for Boerhringer-Ingelheim, Incyte, Qurient, SCM Lifescience and Syneos. He is an investigator for Galderma and Trevi. He has no other potential conflicts including Honoraria, Speakers bureau, Stock ownership or options, Expert testimony, Grants, Patents filed, received, pending, or in preparation, Royalties, or Donation of medical equipment.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.